Romera-Hernández Mónica, Mathä Laura, Steer Catherine A, Ghaedi Maryam, Takei Fumio
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Terry Fox Laboratory British Columbia Cancer, Vancouver, British Columbia, Canada.
Curr Protoc Immunol. 2019 Jun;125(1):e73. doi: 10.1002/cpim.73. Epub 2019 Apr 17.
Innate lymphoid cells (ILCs) are a heterogeneous family of lymphocytes that populate barrier and non-barrier tissues. ILCs regulate immune responses to pathogens and commensals but also sustain metabolic homeostasis, tissue remodeling after injury and establish dialogue with the nervous system. ILCs rapidly become activated in the absence of adaptive antigen receptors by responding to signaling molecules provided by hematopoietic or non-hematopoietic cells. Here we provide protocols designed for processing the lung, liver, small intestine, bone marrow, mediastinal and mesenteric lymph nodes in order to obtain a purified leukocyte fraction of cells, in which ILC2 enrichment is optimized. In addition, we describe in detail the methodologies used to activate ILC2s and the assays necessary for the detection of their effector cytokines. We highlight the differences in ILC2 characterization within distinct tissues that we have recently identified. © 2019 by John Wiley & Sons, Inc.
固有淋巴细胞(ILC)是一类异质性淋巴细胞家族,分布于屏障组织和非屏障组织。ILC调节对病原体和共生菌的免疫反应,还维持代谢稳态、损伤后的组织重塑,并与神经系统建立对话。在缺乏适应性抗原受体的情况下,ILC通过对造血或非造血细胞提供的信号分子作出反应而迅速被激活。在此,我们提供了用于处理肺、肝、小肠、骨髓、纵隔和肠系膜淋巴结的方案,以获得纯化的白细胞组分,其中ILC2的富集得到了优化。此外,我们详细描述了用于激活ILC2的方法以及检测其效应细胞因子所需的测定方法。我们强调了我们最近在不同组织中鉴定出的ILC2特征的差异。© 2019约翰威立国际出版公司